The Colton Consortium for Autoimmunity
LightNews LightNews
banner
coltonconsortium.bsky.social
The Colton Consortium for Autoimmunity
@coltonconsortium.bsky.social
160 followers 700 following 10 posts
Advancing our understanding of human autoimmunity and transforming patient lives through bold, collaborative, and translational science.

Learn more: www.coltonconsortium.org
Posts Replies Media Videos
coltonconsortium.bsky.social
Colton Consortium-affiliated researcher David Fajgenbaum, MD, MBA, MSc joins the Huberman Lab podcast to explore how repurposed, FDA-approved drugs can open new possibilities for #autoimmunity and rare diseases—an approach shaped by his own patient experience.

www.hubermanlab.com/episode/davi...
Using Existing Drugs in New Ways to Treat & Cure Diseases of Brain & Body | Dr. David Fajgenbaum
Dr. David Fajgenbaum shares how he survived Castleman's disease using repurposed drugs and reveals how approved medications can treat diseases beyond their original use.
www.hubermanlab.com
November 21, 2025 at 3:25 PM
coltonconsortium.bsky.social
Join us Nov. 18 for the Colton Consortium Virtual Speaker Series! Hear from David Hafler, MD, FANA (@yaleschoolofmed.bsky.social) a leader in #neuroimmunology, on the gut–brain axis in homeostasis and disease. Registration required: bit.ly/HaflerNov18
Colton Consortium Virtual Speaker Series. David Hafler, MD, FANA. “The Gut–Brain Axis in Homeostasis and Disease." Tues, Nov 18, 2025 (11:00 a.m. ET). Virtual. Registration required.
November 10, 2025 at 3:26 PM
coltonconsortium.bsky.social
Dr. Wherry, Director of the Penn Colton Center for Autoimmunity and the Colton Consortium, spoke with The Philadelphia Inquirer about the future of #immunology + #autoimmunity research at Penn—including a new $367M facility—and beyond: “This is the most exciting time in my lifetime for immunology."
penncoltoncenter.bsky.social The Colton Center for Autoimmunity, University of Pennsylvania @penncoltoncenter.bsky.social · Oct 22
E. John Wherry, PhD, reflected on a conversation with his friend—and new Nobel laureate—Fred Ramsdell, PhD, about the future of #autoimmunity research. Ramsdell’s advice to “stay focused on foundational research” is guiding the direction of Penn’s Colton Center for Autoimmunity. bit.ly/471uuKQ
Penn is expanding its research in immunology — a field just honored with a Nobel Prize
E. John Wherry, director of Penn's Colton Center for Autoimmunity, spoke with the Inquirer about the future of immunology research at Penn and the new $376 million research facility.
www.inquirer.com
October 22, 2025 at 3:08 PM
coltonconsortium.bsky.social
The #ColtonConsortium was proud to serve as lead sponsor of the 2025 FASEB #Autoimmunity Conference in Niagara Falls this summer—an influential gathering that advances autoimmune research and fosters collaboration among scientists and clinicians worldwide. Read the recap: https://bit.ly/46Yk1hZ
October 9, 2025 at 2:05 PM
coltonconsortium.bsky.social
Are you part of the #immunology and #autoimmunity research communities? Join us next week (9/16, 11AM ET) for "Dissection of Autoimmunity Through Outliers" led by Mark Anderson, MD, PhD (UCSF + @ucsfdc.bsky.social)! Registration for this free virtual event is required: bit.ly/AndersonSept16
Colton Consortium Virtual Speaker Series. Dissection of Autoimmunity Through Outliers. Mark Anderson, MD, PhD. Sept. 16, 2025 (11:00 AM ET). Registration required: [QR code]
September 9, 2025 at 6:20 PM
coltonconsortium.bsky.social
Penn Medicine's new #ImmuneHealth research hub will house the @penncoltoncenter.bsky.social, and many other labs and teams engaged in #immunology work, driving bold, cross-disciplinary collaboration to accelerate discoveries in #AutoimmuneDisease research.

www.pennmedicine.org/news/usherin...
Photo of the "overbuild" at 3600 Civic Center Blvd (Philadelphia, PA) at Penn Medicine.
September 8, 2025 at 7:10 PM
coltonconsortium.bsky.social
Join us on 9/16 (11AM ET) for the next session of the Colton Consortium Virtual Speaker Series with Mark Anderson, MD, PhD (UCSF + @ucsfdc.bsky.social), a leading expert in the understanding of autoimmune diseases and their underpinnings. Registration required: bit.ly/AndersonSept16
Colton Consortium Virtual Speaker Series. Mark Anderson, MD, PhD Robert Friend and Michelle M. Friend Endowed Chair in Diabetes Research. University of California, San Francisco. Sept. 16, 2025 (11:00 am ET). Registration required [QR code].
September 4, 2025 at 3:16 PM
coltonconsortium.bsky.social
The 2025 Colton Consortium Symposium brought together leaders, researchers, and partners from Penn, NYU, Yale, and Tel Aviv University to share their scientific breakthroughs and plan the next advances in autoimmune disease research.

🔎 Check out our recap: www.coltonconsortium.org/blog/inside-...
A smiling symposium attendee holds a microphone during an audience Q&A session.
August 13, 2025 at 7:18 PM
coltonconsortium.bsky.social
The Colton Center for Autoimmunity at Yale led a standout session at the 2025 Yale Innovation Summit, spotlighting top researchers from across the #ColtonConsortium. ▶️ Discover how we’re advancing #autoimmune research and accelerating translational breakthroughs:
Colton Center for Autoimmunity Showcase | Yale Innovation Summit 2025
YouTube video by Yale Innovation Summit
www.youtube.com
July 25, 2025 at 6:36 PM
coltonconsortium.bsky.social
Building on the power of the #ColtonConsortium, the Colton Center for Autoimmunity at the University of Pennsylvania @upenn.edu launched two new Centers of Excellence earlier this year to drive groundbreaking advancements in autoimmune diagnostics and therapeutics: bit.ly/4kRTJCT #autoimmunity
Dr. David Fagjenbaum, Associate Professor of Medicine at the University of Pennsylvania and a co-PI of a new Colton Center of Excellence, speaks into a microphone while seated during a Q&A session at the Penn Colton Center for Autoimmunity Symposium in April 2025.
July 24, 2025 at 7:49 PM